CHICAGO

POCKETIN

一起探索心血管醫(yī)學(xué)的未來(lái)

北京時(shí)間3月29日至31日，由美國(guó)心臟病學(xué)會(huì)（ACC）舉辦的心血管領(lǐng)域盛會(huì)——ACC.25學(xué)術(shù)會(huì)議將在美國(guó)隆重舉行。本次為期3天的會(huì)議亮點(diǎn)滿(mǎn)滿(mǎn)，設(shè)有6場(chǎng)最新突破性臨床試驗(yàn)（Late-Breaking Clinical Trials）。POCKETIN基于各大研究注冊(cè)信息及既往公布的相關(guān)研究文獻(xiàn)，推出“LBCT 搶先看”欄目，請(qǐng)您緊跟我們的步伐，一同踏上這場(chǎng)充滿(mǎn)驚喜與挑戰(zhàn)的ACC.25學(xué)術(shù)之旅。

重磅研究，先睹為快

Preview First

6場(chǎng)LBCT

23項(xiàng)最新研究

跟隨我們

提前探秘ACC.25

解鎖心臟醫(yī)學(xué)新進(jìn)展

LBCT日程一覽

Detailed Schedule

Late-Breaking Clinical Trials I

北京時(shí)間：3月29日 22:30-23:30

Primary and Secondary Outcomes of the Women's Ischemia Trial to Reduce Events in Non-Obstructive Coronary Artery Disease
減少女性非阻塞性冠狀動(dòng)脈疾病缺血事件試驗(yàn)的主要和次要結(jié)局
講者：Eileen Handberg
The Effect of Once-weekly Subcutaneous Semaglutide on Functional Capacity in People With Type 2 Diabetes and Peripheral Artery Disease: Primary Results From the Phase 3b, Randomized, Placebo-Controlled, Double Blind Stride Trial
每周一次皮下注射司美格魯肽對(duì)2型糖尿病合并外周動(dòng)脈疾病患者功能能力的影響：3b期隨機(jī)、安慰劑對(duì)照、雙盲STRIDE試驗(yàn)的主要結(jié)果
講者：Marc Bonaca
Extended Anticoagulant Treatment With a Reduced Versus Full Dose Apixaban in Patients With Cancer-Associated Venous Thromboembolism: The API-CAT Study
癌癥相關(guān)靜脈血栓栓塞患者使用減量與全劑量阿哌沙班進(jìn)行延長(zhǎng)抗凝治療：API-CAT研究
講者：Isabelle MAHE

Late-Breaking Clinical Trials II

北京時(shí)間：3月30日 00:30-01:30

Efficacy of Rivaroxaban Versus Warfarin in Patients With Acute Left Ventricular Thrombus Following Myocardial Infarction: An Open-Label Randomized Controlled Trial RIVAWAR Trial Investigators
利伐沙班與華法林在心肌梗死后急性左心室血栓患者中的療效比較：一項(xiàng)開(kāi)放標(biāo)簽隨機(jī)對(duì)照試驗(yàn)（RIVAWAR試驗(yàn)）
講者：Jehangir Ali Shah
Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients With Coagulopathy — Results From a Phase 3, Randomized, Active-Control Study
4因子凝血酶原復(fù)合物濃縮物在出血的成年心臟手術(shù)合并凝血功能障礙患者中的療效優(yōu)于新鮮冰凍血漿——3期隨機(jī)、活性對(duì)照研究結(jié)果
講者：Keyvan Karkouti The Main Results of the Phase 3 Reverse-it Trial
3期REVERSE-IT試驗(yàn)的主要結(jié)果
講者：Deepak Bhatt Stratified Randomization Study to Compare Different Duration of Dual Antiplatelet Therapy After Coronary Stenting in Either High or Low Bleeding Risk Population
比較高或低出血風(fēng)險(xiǎn)人群冠狀動(dòng)脈支架置入術(shù)后不同時(shí)長(zhǎng)雙聯(lián)抗血小板治療的分層隨機(jī)研究
講者：Hyo-Soo Kim

Late-Breaking Clinical Trials III

北京時(shí)間：3月30日 02:30-03:30

Oral Semaglutide Reduces Cardiovascular Events in People With Type 2 Diabetes With Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial
口服司美格魯肽對(duì)患有動(dòng)脈粥樣硬化性心血管疾病和/或慢性腎臟病的2型糖尿病患者心血管事件的影響：SOUL隨機(jī)試驗(yàn)的主要結(jié)果
講者：Darren McGuire
Efficacy of Lorundrostat, A Novel Aldosterone Synthase Inhibitor, In Patients With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen
新型醛固酮合酶抑制劑Lorundrostat在標(biāo)準(zhǔn)化抗高血壓藥物治療方案下對(duì)血壓控制不佳患者的療效
講者：Luke Laffin
Development and External Validation of a Deep Learning Electrocardiogram Model For Risk Stratification of Coronary Revascularization Need in the Emergency Department
急診科用于冠狀動(dòng)脈血運(yùn)重建需求風(fēng)險(xiǎn)分層的深度學(xué)習(xí)心電圖模型的開(kāi)發(fā)與外部驗(yàn)證
講者：Antonius Buescher Dapagliflozin in Patients Undergoing Transcatheter Aortic Valve Implantation
達(dá)格列凈在經(jīng)導(dǎo)管主動(dòng)脈瓣植入術(shù)患者中的應(yīng)用
講者：Sergio Raposeiras Roubin

Late-Breaking Clinical Trials IV

北京時(shí)間：3月30日 21:00-22:00

Comparative Effectiveness of Mobile Integrated Health Versus a Transitions of Care Coordinator in Patients With Heart Failure: Results From the MIGHTy-Heart Trial
心力衰竭患者移動(dòng)綜合健康服務(wù)與護(hù)理過(guò)渡協(xié)調(diào)員的療效比較：MIGHTy-Heart試驗(yàn)結(jié)果
講者：Ruth Masterson Creber
Liberal Fluid Intake Versus Fluid Restriction in Chronic Heart Failure
慢性心力衰竭患者自由液體攝入與限制液體攝入的比較
講者：Roland Van Kimmenade The Equiox Study: Evaluating Pulse Oximeter Bias Across a Range of Skin Pigment in Critically Ill Adults
EQUIOX研究：評(píng)估危重癥成人不同膚色下脈搏血氧儀的偏差
講者：Carolyn Hendrickson Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF2) Trial
羧麥芽糖鐵對(duì)缺鐵性貧血合并慢性心力衰竭患者發(fā)病率和死亡率影響的評(píng)估（FAIR-HF2）試驗(yàn)
講者：Stefan Anker

Late-Breaking Clinical Trials V

北京時(shí)間：3月30日 23:00-24:00

Routine Cerebral Embolic Protection in Transcatheter Aortic Valve Implantation: The British Heart Foundation (BHF) PROTECT-TAVI Trial
經(jīng)導(dǎo)管主動(dòng)脈瓣植入術(shù)中常規(guī)腦栓塞保護(hù)：英國(guó)心臟基金會(huì)（BHF）PROTECT-TAVI試驗(yàn)
講者：Rajesh Kharbanda
Clinical And Echocardiographic Outcomes Among the First 500 Patients Treated With a Dedicated Transcatheter Aortic Valve For Pure Aortic Regurgitation in the Align-AR Clinical Trial
Align-AR臨床試驗(yàn)中首批500例接受專(zhuān)用經(jīng)導(dǎo)管主動(dòng)脈瓣治療單純主動(dòng)脈瓣反流患者的臨床和超聲心動(dòng)圖結(jié)果
講者：Raj Makkar 5-year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
低風(fēng)險(xiǎn)主動(dòng)脈瓣狹窄患者經(jīng)導(dǎo)管或外科主動(dòng)脈瓣置換術(shù)后5年結(jié)局
講者：Michael Reardon Comparison of Angiography-Derived Fractional Flow Reserve-Guided and Intravascular Ultrasound-Guided Percutaneous Coronary Intervention Strategies: The FLAVOUR II Trial
血管造影衍生的血流儲(chǔ)備分?jǐn)?shù)指導(dǎo)與血管內(nèi)超聲指導(dǎo)的經(jīng)皮冠狀動(dòng)脈介入治療策略比較：FLAVOUR II試驗(yàn)
講者：浙江大學(xué)醫(yī)學(xué)院附屬第二醫(yī)院 王建安

Late-Breaking Clinical Trials VI

北京時(shí)間：3月31日 00:30-01:30

Two-Year Outcomes of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The Triluminate Pivotal Trial
經(jīng)導(dǎo)管三尖瓣緣對(duì)緣修復(fù)治療三尖瓣反流的2年結(jié)局：Triluminate關(guān)鍵試驗(yàn)
講者：Saibal Kar
Fractional Flow Reserve Guided Percutaneous Coronary Intervention Compared With Bypass Surgery: Final 5 Year Results of the Fractional Flow Reserve Versus Angiography For Multivessel Evaluation 3 Trial
血流儲(chǔ)備分?jǐn)?shù)指導(dǎo)的經(jīng)皮冠狀動(dòng)脈介入治療與冠狀動(dòng)脈搭橋手術(shù)的比較：多支病變FFR vs. 造影評(píng)估（FAME）3試驗(yàn)的最終5年結(jié)果
講者：William Fearon Clopidogrel Versus Aspirin For Long-Term Maintenance Monotherapy in Patients With High Ischemic Risk After Percutaneous Coronary Intervention
氯吡格雷與阿司匹林在經(jīng)皮冠狀動(dòng)脈介入術(shù)后高缺血風(fēng)險(xiǎn)患者長(zhǎng)期維持單藥治療中的比較
講者：Joo-Yong Hahn Alliance For Secondary Prevention After an Acute Coronary Syndrome
急性冠狀動(dòng)脈綜合征后二級(jí)預(yù)防聯(lián)盟
講者：Giulia Magnani

更多精彩 敬請(qǐng)期待

全面工作

傳播矩陣

FOLLOW US

• 蘇州工業(yè)園區(qū)東方華夏心血管健康研究院

• 電話(huà)：0512-68295918

• 郵箱：info@ccahouse.org

• 網(wǎng)址：https://www.ccahouse.org

• 地址：蘇州工業(yè)園區(qū)水坊路36號(hào)姑蘇會(huì)平江館心臟之家